NEWTOWN, Pa., July 12, 2024 /PRNewswire/ — Edelson Lechtzin LLP, a leading class action law firm, reminds investors about the impending deadline to seek appointment as lead plaintiff in the securities fraud class action lawsuit against Bolt Biotherapeutics, Inc. (NASDAQ: BOLT). If you…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.